Ware Grove
Analyst · William Blair & Company
Thank you, Jerry, and good morning, everyone. Considering the exceptionally strong results we reported in the first quarter a year ago, together with the impact of the divestitures we announced at the end of 2018, we expected the first quarter results this year would likely not reflect the level of year-over-year growth that is consistent with our full year guidance for 2019. The strong performance in the transactional businesses last year, coupled with the loss of revenue from the divestitures that effectively neutralize the growth we would have otherwise achieved, impacted our total revenue growth by approximately 150 basis points in the first quarter of this year compared with prior year. Our business is healthy, client demand is strong and we want to affirm that we are comfortable with our full year 2019 growth targets and guidance. Considering the impact of continued investments we are making in the business, we're happy to report a margin increase of 60 basis points compared with the first quarter a year ago. We have a continuing investment in new business producers within our Benefits and Insurance group. As many of you understand, this is a multi-year effort for us as it takes time for newly hired individuals to ramp up to generate new business production to target levels. With the increased hiring in the second half of last year and continuing into the first quarter this year, the incremental cost incurred impacted first quarter margin by approximately 28 basis points. As Jerry commented, we are seeing positive trends with stronger first quarter production and higher client retention rates. And we expect to reflect improving performance within our Benefits and Insurance business by the end of the year. As noted in the release issued this morning, we've been active with share repurchases. Through the end of the first quarter, we repurchased approximately 580,000 shares of our common stock at a cost of approximately $11.6 million. And through April 24 this year, we have repurchased a total of approximately 612,000 shares. With our seasonal trend to use cash in the first quarter, cash flow for the business is as expected. And the debt level at the end of the first quarter this year was at 1.7 times EBITDA. Our priority continues to be to use capital for strategic acquisitions. But with nearly $210 million of unused borrowing capacity, we also have the flexibility to continue an active approach towards share repurchases. Now as a result of recent share repurchase activity, we expect full year 2019 fully diluted weighted average share count within a range of $56 million to $56.5 million, and this is a slight reduction from our earlier year guidance. In the first quarter, we used approximately $4.4 million of cash for payments on acquisitions. For the remainder of this year, for prior year acquisition-related payments, we forecast the use of approximately $14 million; and for next year 2020, approximately $11.5 million; for 2021, approximately $4.9 million; and then for 2022, approximately $2.7 million. Day sales outstanding on receivables at the end of the first quarter this year was 91 days compared with 92 days a year ago. Remember, the seasonal nature of our business causes a rise in day sales outstanding in the first half of the year as revenues generated with billing and payment activity to occur later in the year. Capital spending in the first quarter was $5.4 million, largely driven by facilities moves and related tenant build-out costs. In addition, we are transitioning to purchase rather than lease some IT equipment. As a result, for the full year of this year, we expect capital spending of approximately $12 million. I want to remind you of the impact of accounting for gains and losses and the deferred compensation plan for CBIZ. At March 31, we have approximately $96 million of assets in this plan. And you'll see a significant $9.1 million first quarter gain that impacts reported results. And this is outlined in the notes that accompany our earnings release. Eliminating the impact from the GAAP reported operating expenses and general and administrative expenses, gross margin improved by 10 basis points compared with a year ago. And general and administrative expense was 4% of revenue compared with 3.8% a year ago, primarily due to investment in technology and systems and stock compensation-related expenses compared with the prior year. The effective tax rate in the first quarter was 26.6%, and we continue to project a full year tax rate of approximately 25%. The tax rate will be impacted by stock compensation accounting and this could be either higher or lower depending on subsequent activity over the balance of this year. As a heads up, I want to note that we adopted the new lease accounting standard at January 1, 2019. There is no impact to earnings or cash flow nor is there any impact to our credit agreement or credit availability. But when we issue a full balance sheet in our upcoming first quarter 10-Q filing, you will find a right-to-use asset on the balance sheet that is offset by a present value liability for future lease payments. Looking ahead to the balance of the year, business conditions are favorable and we expect continued strong client demand for services. Government health care consulting continues to grow at high single-digit rates. Our financial and transactional advisory business continues to see robust demand for services. First quarter tax work was softer than expected as a result of delays in IRS regulations and guidance. But with a larger number of extensions filed to date, this work will be done later in the year. As a result of the investments we are making in new producers, we expect improving revenue growth trends within our Benefits and Insurance business segment through the balance of this year. So with these factors in mind, I want to recap our full year 2019 guidance. We expect total revenue growth within a range of 4% to 6% over the $922 million we reported in 2018. We expect the effective tax rate for the full year 2019 will be approximately 25%. The first quarter effective tax rate was 26.6%, but estimating the expected impact of full year stock compensation expense, we continue to expect a full year rate of approximately 25%. And again, a number of unpredictable factors could cause the full year rate to be either higher or lower than our estimate. Considering the recent share repurchase activity, the full year weighted average fully diluted share count is now estimated within a range of $56 million to $56.5 million [ph] compared, I’m sorry, shares, compared with 56.5 million shares for 2018. We expect full year growth in earnings per share within a range of 10% to 12% higher than the $1.09 per share we reported for the full year 2018. So with these comments, I'll conclude and I'll turn it back over to Jerry.